TMEM101
gene geneOn this page
Also known as MGC4251FLJ23987
Summary
TMEM101 (transmembrane protein 101, HGNC:28653) is a protein-coding gene on chromosome 17q21.31, encoding Transmembrane protein 101 (Q96IK0). May activate NF-kappa-B signaling pathways.
Involved in positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in membrane.
Source: NCBI Gene 84336 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 18 total
- MANE Select transcript:
NM_032376
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28653 |
| Approved symbol | TMEM101 |
| Name | transmembrane protein 101 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC4251, FLJ23987 |
| Ensembl gene | ENSG00000091947 |
| Ensembl biotype | protein_coding |
| Entrez | 84336 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000206380, ENST00000585950, ENST00000586174, ENST00000587529, ENST00000589334, ENST00000590905, ENST00000591162, ENST00000592127, ENST00000860792
RefSeq mRNA: 3 — MANE Select: NM_032376
NM_001304813, NM_001304814, NM_032376
CCDS: CCDS11474
Canonical transcript exons
ENST00000206380 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000588523 | 44014816 | 44014963 |
| ENSE00003892239 | 44011188 | 44012236 |
| ENSE00003895501 | 44013009 | 44013155 |
| ENSE00003895562 | 44014357 | 44014537 |
Expression profiles
Bgee: expression breadth ubiquitous, 235 present calls, max score 95.09.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.7027 / max 94.9461, expressed in 1794 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166291 | 16.6704 | 1790 |
| 166293 | 0.0163 | 6 |
| 166292 | 0.0101 | 4 |
| 166294 | 0.0059 | 3 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| metanephros cortex | UBERON:0010533 | 95.09 | gold quality |
| endometrium | UBERON:0001295 | 94.41 | gold quality |
| seminal vesicle | UBERON:0000998 | 93.21 | gold quality |
| body of pancreas | UBERON:0001150 | 91.54 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.28 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 91.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.37 | gold quality |
| body of stomach | UBERON:0001161 | 90.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 90.02 | gold quality |
| right uterine tube | UBERON:0001302 | 89.68 | gold quality |
| buccal mucosa cell | CL:0002336 | 89.61 | gold quality |
| apex of heart | UBERON:0002098 | 89.59 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.02 | gold quality |
| left testis | UBERON:0004533 | 88.97 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.94 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.73 | gold quality |
| right testis | UBERON:0004534 | 88.64 | gold quality |
| muscle of leg | UBERON:0001383 | 88.61 | gold quality |
| endocervix | UBERON:0000458 | 88.52 | gold quality |
| granulocyte | CL:0000094 | 88.42 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.37 | gold quality |
| minor salivary gland | UBERON:0001830 | 88.33 | gold quality |
| body of uterus | UBERON:0009853 | 88.29 | gold quality |
| pancreas | UBERON:0001264 | 88.25 | gold quality |
| skin of leg | UBERON:0001511 | 88.25 | gold quality |
| vagina | UBERON:0000996 | 88.24 | gold quality |
| monocyte | CL:0000576 | 88.20 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.05 | gold quality |
| leukocyte | CL:0000738 | 87.95 | gold quality |
| testis | UBERON:0000473 | 87.86 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10287 | yes | 50.05 |
| E-CURD-119 | yes | 44.50 |
| E-ANND-3 | yes | 12.02 |
| E-MTAB-6678 | yes | 9.92 |
| E-MTAB-7606 | no | 1255.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting TMEM101, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-4527 | 99.66 | 67.43 | 714 |
| HSA-MIR-6503-5P | 99.62 | 66.96 | 597 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-6505-3P | 99.34 | 67.39 | 1071 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-4520-2-3P | 99.14 | 69.28 | 1009 |
| HSA-MIR-3164 | 99.02 | 68.39 | 1071 |
| HSA-MIR-6820-3P | 99.02 | 68.50 | 1035 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-548Q | 98.71 | 65.35 | 563 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem101 | ENSDARG00000114508 |
| mus_musculus | Tmem101 | ENSMUSG00000020921 |
| rattus_norvegicus | Tmem101 | ENSRNOG00000054581 |
Protein
Protein identifiers
Transmembrane protein 101 — Q96IK0 (reviewed: Q96IK0)
Alternative names: Putative NF-kappa-B-activating protein 130
All UniProt accessions (5): Q96IK0, K7EM07, K7EM72, K7EPU9, K7ERS4
UniProt curated annotations — full annotation on UniProt →
Function. May activate NF-kappa-B signaling pathways.
Subcellular location. Membrane.
RefSeq proteins (3): NP_001291742, NP_001291743, NP_115752* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029371 | TMEM101 | Family |
Pfam: PF15111
UniProt features (9 total): transmembrane region 8, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96IK0-F1 | 89.34 | 0.60 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 121 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, LUND_SILENCED_BY_METHYLATION, SMID_BREAST_CANCER_LUMINAL_B_UP, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, HAN_SATB1_TARGETS_DN, GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, SCGGAAGY_ELK1_02, ER_Q6_01, HATADA_METHYLATED_IN_LUNG_CANCER_UP, ZWANG_EGF_INTERVAL_DN, ALKBH3_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES, FOXN3_TARGET_GENES
GO Biological Process (1): positive regulation of canonical NF-kappaB signal transduction (GO:0043123)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| canonical NF-kappaB signal transduction | 1 |
| regulation of canonical NF-kappaB signal transduction | 1 |
| positive regulation of intracellular signal transduction | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
554 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM101 | TMEM223 | A0PJW6 | 562 |
| TMEM101 | TMEM208 | Q9BTX3 | 510 |
| TMEM101 | RPP40 | O75818 | 506 |
| TMEM101 | TMEM59L | Q9UK28 | 486 |
| TMEM101 | FAM181B | A6NEQ2 | 477 |
| TMEM101 | TMEM115 | Q12893 | 472 |
| TMEM101 | CDKL2 | Q92772 | 445 |
| TMEM101 | LAGE3 | Q14657 | 445 |
| TMEM101 | LCA5 | Q86VQ0 | 432 |
| TMEM101 | GATAD1 | Q8WUU5 | 429 |
| TMEM101 | CDC23 | Q9UJX2 | 414 |
| TMEM101 | KRCC1 | Q9NPI7 | 412 |
| TMEM101 | FHAD1 | B1AJZ9 | 411 |
| TMEM101 | NTRK1 | P04629 | 402 |
| TMEM101 | UBIAD1 | Q9Y5Z9 | 389 |
IntAct
65 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STRIT1 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM243 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX10 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NINJ2 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM101 | BNIP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAMP1 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARLN | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM65 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BNIP3 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAMP2 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDZK1IP1 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM101 | TMEM243 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAPB | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM101 | NINJ2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM101 | PKMYT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFA3 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (33): TMEM101 (Affinity Capture-RNA), STX10 (Two-hybrid), VAPB (Two-hybrid), PKMYT1 (Two-hybrid), TMEM243 (Two-hybrid), VAMP1 (Two-hybrid), PDZK1IP1 (Two-hybrid), C4orf3 (Two-hybrid), TMEM65 (Two-hybrid), NDUFA3 (Two-hybrid), NINJ2 (Two-hybrid), BNIP3 (Two-hybrid), TMIE (Two-hybrid), GIMAP1 (Two-hybrid), SYNJ2BP (Two-hybrid)
ESM2 similar proteins: A0A0N0DCA4, A0A194XK05, A0A7L9EZ67, A0A8F4NUZ8, A0A8F4S726, C6Y4A4, D2I2F3, G5EEQ9, O94440, P0DXW0, P32564, P34296, P53748, Q0VD15, Q10255, Q10436, Q12155, Q29RQ9, Q3B8H0, Q53FV1, Q55E32, Q5E972, Q5R570, Q5R8X5, Q5RFN8, Q5VVB8, Q5XH57, Q5XJR6, Q5ZIU0, Q6NZZ4, Q6QI25, Q6UX40, Q74ZU2, Q86H65, Q8JFB7, Q8N138, Q8STK5, Q8SW90, Q91VP7, Q921I0
Diamond homologs: Q2KIB3, Q5RFN8, Q91VP7, Q96IK0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 17 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
942 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:44013151:CGGAC:C | acceptor_gain | 1.0000 |
| 17:44013162:C:CT | acceptor_gain | 1.0000 |
| 17:44013163:G:T | acceptor_gain | 1.0000 |
| 17:44014351:GCTCA:G | donor_loss | 1.0000 |
| 17:44014352:CTCA:C | donor_loss | 1.0000 |
| 17:44014353:TCACC:T | donor_loss | 1.0000 |
| 17:44014354:CACCT:C | donor_loss | 1.0000 |
| 17:44014355:A:AC | donor_gain | 1.0000 |
| 17:44014356:C:CC | donor_gain | 1.0000 |
| 17:44014356:CCTT:C | donor_gain | 1.0000 |
| 17:44014546:C:CT | acceptor_gain | 1.0000 |
| 17:44014547:G:T | acceptor_gain | 1.0000 |
| 17:44014551:G:C | acceptor_gain | 1.0000 |
| 17:44014551:G:GC | acceptor_gain | 1.0000 |
| 17:44012232:TAGGC:T | acceptor_gain | 0.9900 |
| 17:44012234:GGCC:G | acceptor_loss | 0.9900 |
| 17:44012235:GCC:G | acceptor_loss | 0.9900 |
| 17:44012237:C:CC | acceptor_gain | 0.9900 |
| 17:44013004:CAT:C | donor_loss | 0.9900 |
| 17:44013007:A:AC | donor_gain | 0.9900 |
| 17:44013007:ACC:A | donor_loss | 0.9900 |
| 17:44013008:C:CC | donor_gain | 0.9900 |
| 17:44013008:C:CT | donor_gain | 0.9900 |
| 17:44013008:CCA:C | donor_gain | 0.9900 |
| 17:44013008:CCACA:C | donor_gain | 0.9900 |
| 17:44013155:CCTAG:C | acceptor_loss | 0.9900 |
| 17:44013156:C:CC | acceptor_gain | 0.9900 |
| 17:44014355:AC:A | donor_gain | 0.9900 |
| 17:44014356:CC:C | donor_gain | 0.9900 |
| 17:44014356:CCT:C | donor_gain | 0.9900 |
AlphaMissense
1640 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:44014474:A:C | S67R | 0.999 |
| 17:44014474:A:T | S67R | 0.999 |
| 17:44014476:T:G | S67R | 0.999 |
| 17:44012002:A:G | W234R | 0.998 |
| 17:44012002:A:T | W234R | 0.998 |
| 17:44013029:C:G | G149R | 0.995 |
| 17:44013099:G:C | S125R | 0.995 |
| 17:44013099:G:T | S125R | 0.995 |
| 17:44013101:T:G | S125R | 0.995 |
| 17:44014868:A:G | W29R | 0.995 |
| 17:44014868:A:T | W29R | 0.995 |
| 17:44012029:A:G | W225R | 0.993 |
| 17:44012029:A:T | W225R | 0.993 |
| 17:44013043:C:T | G144D | 0.993 |
| 17:44013119:C:G | G119R | 0.993 |
| 17:44013121:C:T | G118D | 0.993 |
| 17:44013122:C:G | G118R | 0.993 |
| 17:44013130:G:T | A115D | 0.993 |
| 17:44011959:C:T | G248E | 0.992 |
| 17:44014365:A:G | W104R | 0.992 |
| 17:44014365:A:T | W104R | 0.992 |
| 17:44012000:C:A | W234C | 0.991 |
| 17:44012000:C:G | W234C | 0.991 |
| 17:44012027:C:A | W225C | 0.991 |
| 17:44012027:C:G | W225C | 0.991 |
| 17:44013044:C:G | G144R | 0.991 |
| 17:44014441:G:C | F78L | 0.991 |
| 17:44014441:G:T | F78L | 0.991 |
| 17:44014443:A:G | F78L | 0.991 |
| 17:44014478:G:T | A66D | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000233251 (17:44013649 ACT>A), RS1000506535 (17:44016707 A>C), RS1000612799 (17:44022939 C>T), RS1000959208 (17:44018620 G>A), RS1001011597 (17:44018136 A>C), RS1001213873 (17:44016339 A>G), RS1001629646 (17:44021201 AG>A), RS1001922267 (17:44023874 G>A), RS1002288829 (17:44024083 C>A,G,T), RS1002310749 (17:44015084 G>C,T), RS1002481557 (17:44018074 G>A), RS1002569675 (17:44017664 G>A), RS1002588511 (17:44018394 G>A,C,T), RS1002954394 (17:44014304 C>G,T), RS1002985435 (17:44014633 C>A,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| coumarin | increases phosphorylation | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Estradiol | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Smoke | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.